Filing Details

Accession Number:
0001209191-20-019140
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-16 12:51:36
Reporting Period:
2020-03-12
Accepted Time:
2020-03-16 12:51:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1117480 Chimerix Inc CMRX Pharmaceutical Preparations (2834) 330903395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509463 A. Michael Sherman 2505 Meridian Parkway, Suite 100
Durham NC 27713
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-12 72,995 $1.45 102,995 No 4 P Indirect By Sherman Investors LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Sherman Investors LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,690 Direct
Footnotes
  1. The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.37 to $1.41, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
  2. Includes 4,690 shares of Common Stock that were acquired by the Reporting Person on March 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan.